Skip to main content
Clinical Trials/NCT03751566
NCT03751566
Recruiting
Not Applicable

Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors

Masaryk Memorial Cancer Institute1 site in 1 country60 target enrollmentOctober 5, 2021

Overview

Phase
Not Applicable
Intervention
Standard supportive therapy
Conditions
Malignant Tumor of Soft Tissue of Head, Face and Neck
Sponsor
Masaryk Memorial Cancer Institute
Enrollment
60
Locations
1
Primary Endpoint
Management of acute toxicity of radiotherapy with acupuncture: Reducing the grade of acute toxicity in radiotherapy
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The aim of the study is to evaluate the benefit of the acupuncture as healing modalities in the therapy of acute toxicity of radiotherapy.

Detailed Description

The study will enroll 100 patients in current radiotherapy of the head and neck cancer with acute radiotoxic symptoms at least of G1. The patients will be randomized (by ticket) in two regimens 1:1. Regimen A (control regimen): standard support treatment of adverse events of the radiotherapy. Regimen B (acupuncture regimen): standard support treatment of adverse events of the radiotherapy and acupuncture. Due to the disease and patients differences, treatment will be individualized. Used acupuncture points will be documented. The patients difficulties will be observed and their medication and will be recorded in the patient diary. Possible skin toxicities wil be documented by the photography. Before the randomization, all subjects will sign the voluntary informed consent. After the achievement of 50 enrolled subjects in any regimen, the enrollment will continue only to the other regimen. Head and neck cancer therapy will include only curative and adjuvant radiotherapy.

Registry
clinicaltrials.gov
Start Date
October 5, 2021
End Date
October 4, 2026
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Curative and adjuvant radiotherapy for head and neck tumors;
  • Patient collaboration in evaluation of the toxicity diary.

Exclusion Criteria

  • Palliative radiotherapy in the head and neck tumor;
  • Non-compliance of the patient.

Arms & Interventions

Regimen A

Regimen A (control regimen): standard support treatment of adverse events of the radiotherapy.

Intervention: Standard supportive therapy

Regimen B

Regimen B (acupuncture regimen): standard support treatment of adverse events of the radiotherapy and acupuncture.

Intervention: Acupuncture

Regimen B

Regimen B (acupuncture regimen): standard support treatment of adverse events of the radiotherapy and acupuncture.

Intervention: Standard supportive therapy

Outcomes

Primary Outcomes

Management of acute toxicity of radiotherapy with acupuncture: Reducing the grade of acute toxicity in radiotherapy

Time Frame: six months after the end of radiotherapy

Reducing the grade of acute toxicity in radiotherapy.

Secondary Outcomes

  • Management of chronic toxicity of radiotherapy with acupuncture: Lower incidence of chronic toxicity of radiotherapy(six months after the end of radiotherapy)

Study Sites (1)

Loading locations...

Similar Trials